1.
Clayton R, Wu J, Heng DY, North SA, Emmenegger U, Hotte S, Chi K, Zielinski R, Al-Shamsi H, Chen L, Eigl B. A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration resistant prostate cancer. CUAJ [Internet]. 2014 Sep. 9 [cited 2022 May 28];8(9-10):e583-90. Available from: https://cuaj.ca/index.php/journal/article/view/1891